HCP Live

NCCN 2010: Dr. Lee Krug, Memorial Sloan-Kettering Cancer Center

Mar 17, 2010

Lee M. Krug, MD of the Memorial Sloan-Kettering Cancer Center speaks about New NCCN Guidelines for Mesothelioma at the 15th Annual NCCN Conference in Hollywood, FL March, 2010.

Related Videos

Brian LaMoreaux, MD | Credit: Horizon Therapeutics

Natalie McCormick, PhD | Credit: American College of Rheumatology

Brian LaMoreaux, MD | Credit: Horizon Therapeutics

Victor Kim, MD: Addressing Comorbidities and Advancing COPD Care

Victor-Kim-MD

Cedric Rutland, MD: Exploring Immunology's Role in Molecule Development

Panagis Galiatsatos, MD: Closing the Gap in Lung Cancer Screening

Related Content

SEL-212 Significantly Reduces Serum Uric Acid Levels in Patients With Gout

Lungcast: Live From ATS 2023 with Anne Dixon, MD

Major Clinical Response Lower in Black, Indo-Asian Patients With SLE

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

April 23rd 2023

MRI Data Details Impact of Apremilast in People with Psoriatic Arthritis

Severe Asthma Management: Exploring the Mechanism of Action in Tezepelumab and Omalizumab

SEL-212 Significantly Reduces Serum Uric Acid Levels in Patients With Gout

Lungcast: Live From ATS 2023 with Anne Dixon, MD

Major Clinical Response Lower in Black, Indo-Asian Patients With SLE

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

April 23rd 2023

MRI Data Details Impact of Apremilast in People with Psoriatic Arthritis

Severe Asthma Management: Exploring the Mechanism of Action in Tezepelumab and Omalizumab

SEL-212 Significantly Reduces Serum Uric Acid Levels in Patients With Gout

Lungcast: Live From ATS 2023 with Anne Dixon, MD

Major Clinical Response Lower in Black, Indo-Asian Patients With SLE

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

April 23rd 2023

MRI Data Details Impact of Apremilast in People with Psoriatic Arthritis

Severe Asthma Management: Exploring the Mechanism of Action in Tezepelumab and Omalizumab

Related Content

SEL-212 Significantly Reduces Serum Uric Acid Levels in Patients With Gout

SEL-212 Significantly Reduces Serum Uric Acid Levels in Patients With Gout

Live From ATS 2023 with Anne Dixon, MD

Lungcast: Live From ATS 2023 with Anne Dixon, MD

Major Clinical Response Lower in Black, Indo-Asian Patients With SLE

Major Clinical Response Lower in Black, Indo-Asian Patients With SLE

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

April 23rd 2023

Mikkel Østergaard, MD, Phd, MSc | Credit: Copenhagen University Hospitals

MRI Data Details Impact of Apremilast in People with Psoriatic Arthritis

Severe Asthma Management: Exploring the Mechanism of Action in Tezepelumab and Omalizumab

Severe Asthma Management: Exploring the Mechanism of Action in Tezepelumab and Omalizumab

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.